News 'Bionic eye' receives FDA fast-track review designation Review of Second Sight's Orion will now be streamlined.
News FDA to streamline access to consumer genetic tests New regulations require less pre-market data for approval.
News FDA approvals expand reach of Roche's Zelboraf and Alecensa New US indications for Zelboraf and Alecensa
News FDA approves Valeant eye drug after manufacturing delay Regulator backs potential blockbuster ophthalmology drug
News Severino takes the helm at Sarepta after turbulent spell Around five months after long-serving CEO Doug Ingram said he was stepping down, Sarepta has named industry veteran Michael Severino to replace him.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
